1. Bridging Decision Analytic Modelling with a Cross-Sectional Study

   • Mark J.C. Nuijten

   Leading Article 22 September 2012 Pages: 227 - 236

   

2. ACE Inhibitors after Myocardial Infarction

   • Andrew P. Davie

   Review Article 22 September 2012 Pages: 237 - 243

   

3. Clinical and Economic Factors Important to Anaesthetic Choice for Day-Case Surgery

   • Edmond I. Eger
   • Paul F. White
   • Martin S. Bogetz

   Review Article 22 September 2012 Pages: 245 - 262

   

4. Evaluating the Potential ‘Economic Attractiveness’ of New Therapies in Patients with Non-ST Elevation Acute Coronary Syndrome

   • Eric L. Eisenstein
   • Eric D. Peterson
   • Daniel B. Mark

   Original Research Article 22 September 2012 Pages: 263 - 272

   

5. Assessing Health Utilities in Schizophrenia

   • Lakshmi N. P. Voruganti
   • A. George Awad
   • Ravinder Dhawan

   Original Research Article 22 September 2012 Pages: 273 - 286

   

6. Economics of the Antithymocyte Globulins Thymoglobulin® and Atgam® in the Treatment of Acute Renal Transplant Rejection

   • Mark A. Schnitzler
   • Robert S. Woodward
   • Daniel C. Brennan

   Original Research Article 22 September 2012 Pages: 287 - 293

   

7. The Cost Effectiveness of Misoprostol Prophylaxis Alongside Long Term Nonsteroidal Anti-Inflammatory Drugs

   • Peter J. Davey
   • Eric Meyer

   Original Research Article 22 September 2012 Pages: 295 - 304

   

8. Household Income Losses Associated With Ischaemic Heart Disease For US Employees

   • Jeph Herrin
   • Charles B. Cangialose
   • David J. Ballard

   Original Research Article 22 September 2012 Pages: 304 - 314